Why are you looking at Elusys Therapeutics?
Capability
Service linesPHARMACEUTICAL PREPARATION MANUFACTURING · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS
Where they win
Sole agencyMostly sole-source · 101%
101% of Elusys Therapeutics’s obligations are not openly competed — these contracts typically renew with the incumbent rather than going to recompete.
Agency buyer map
1 buyersRecompete exposure
NoneLargely sole-source — these contracts typically renew with Elusys Therapeutics rather than being openly recompeted.
No incumbent recompetes detected in the next 24 months.
No incumbent recompetes detected in the next 24 months.
GET THE FULL BRIEF
Get Elusys Therapeutics’s recompete exposure, top agencies and teaming history
The outlook above is free to read and verify — an estimated $113.9M in play. Enter a work email for two figures the page cannot show.
“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Elusys Therapeutics hold?
Elusys Therapeutics (UEI ELP1DCK8L191) shows $113.9M across 5 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
Which agencies does Elusys Therapeutics work with?
Elusys Therapeutics’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%).
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →